ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,057Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 42

$963K Total Retail Price of All Prescriptions

Rank: 1 out of 42

484 Patients Receiving at Least One Drug in Part D
29%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

67% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 54%.

Schedule Three
Controlled Substances

49% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 42%.

Risky Drugs to Seniors

11% of this provider’s 2,673 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 16%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,939 633 S3 1 1
CARISOPRODOL 892 86 R 2 10
OXYCODONE HCL 734 73 S2 3 3
MORPHINE SULFATE ER 630 165 S2 4 5
METHADONE HCL 583 120 S2 5 7
ENDOCET 502 92 S2 6 11
OXYCODONE HCL-ACETAMINOPHEN 502 154 S2 6 6
GABAPENTIN 494 98 8 2
TIZANIDINE HCL 461 43 9 4
FENTANYL 372 159 S2 10 8
TRAMADOL HCL 358 106 11 9
ZOLPIDEM TARTRATE 338 96 12 14
OXYCONTIN 278 53 S2 13 18
PROMETHAZINE HCL 267 46 R 14 20
CYCLOBENZAPRINE HCL 212 71 R 15 12
DOXEPIN HCL 199 38 16 36
OXYCODONE-ACETAMINOPHEN 161 31 S2 17 15
TRAZODONE HCL 147 28 18 29
MELOXICAM 145 20 19 17
LIDODERM 142 27 20 27
ROPINIROLE HCL 132 0 21 31
AMITRIPTYLINE HCL 130 38 R 22 19
VOLTAREN 105 0 23 28
OMEPRAZOLE 97 13 24 41
MORPHINE SULFATE 95 0 S2 25 23
LYRICA 92 0 26 13
BACLOFEN 91 0 27 16
PAROXETINE HCL 87 26 28 44
VENLAFAXINE HCL ER 86 0 29 50
TOPIRAMATE 84 0 30 24
METHOCARBAMOL 79 41 R 31 25
OPANA ER 75 11 S2 32 32
CYMBALTA 67 0 33 22
CELEBREX 66 0 34 34
FLUOXETINE HCL 63 0 35 43
SERTRALINE HCL 60 0 36 40
ALPRAZOLAM 56 15 37 60
SUMATRIPTAN SUCCINATE 54 0 38 62
IBUPROFEN 50 19 39 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.